Useful Construction

By Drew Endy FEATUREIs This Life?Useful Construction How to design a chassis for synthetic biological systems Drew Endy is an assistantprofessor in the biologicalengineering division andcofounder of MassachusettsInstitute of Technology's syntheticbiology working group.Creation implies an act that is based on some combinationof perfect

Written byDrew Endy
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Creation implies an act that is based on some combinationof perfect knowledge, unlimited power, and infiniteresources. Gods create. Engineers on the other hand,from structural to electrical and now biological, arealways constrained by (1) an imperfect understandingof raw materials, (2) limited abilities to manipulate these materials,and (3) a budget. As a result, engineers construct. The art of engineeringis to reliably construct useful and beautiful artifacts despiteour limits.

In synthetic biology, there is now tremendous excitement aboutconstructing fully functioning cells from scratch. Unlike past scientificresearch - for example, sequencing of the human genome - the raceto construct synthetic cells has no finish line. Instead, synthetic cellswill be judged on their elegance of design, functional prowess, andsafety features, all characteristics that can be continuously improved.For comparison, would you want to drive your car across the world'sfirst "minimal" bridge?

As one or more of the remarkably diverse approaches toconstruct synthetic cells succeed, the resulting ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies